Injective Ranks 4th as L1 Revenue Gains More Focus
Covered by 1 source · 1 article
In this story
Injective is gaining attention as investors place greater emphasis on blockchain revenue and valuation metrics. The network says its price-to-sales position ranks fourth among Layer-1 networks, while trading activity, token burns, and expan…
Covered by
